RGCRegencell Bioscience Holdings Limited Ordinary Shares

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · regencellbioscience.com

5.300USDMkt Cap: 2.62B $P/E: —3d ago

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocogn…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.19BUSDP/E 23.7

TAK

Takeda Pharmaceutical Co. Ltd.

$58.06BUSD

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$43.98BUSDP/E 20.4

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

Neurocrine Biosciences, Inc.

$15.51BUSDP/E 22.3

ELAN

Elanco Animal Health Incorporat

$11.98BUSD

RDY

Dr. Reddy's Laboratories Ltd

Hims & Hers Health, Inc.

$7.88BUSD

LNTH

Lantheus Holdings Inc

$6.53BUSDP/E 23.9

AMRX

Amneal Pharmaceuticals, Inc. Class A

Kiniksa Pharmaceuticals, Ltd.

$6.08BUSDP/E 79.8

Key Statistics

Company

Market Cap2.62B $

Enterprise Value2.69B $

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-7.05M $

Revenue/Share—

Last Price5.300 USD

Fiscal Year EndJun 2025

MR QuarterDec 2025

Employees10

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-380.43

EV/Revenue—

P/S—

P/B2720.00

EPS (TTM)-0.01

EPS (Forward)—

52W Range

5.22029% of range5.500

52W High5.500 USD

52W Low5.220 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-177.66%

ROA-84.97%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-4.00M $

CapEx (TTM)5.38K $

FCF Margin—

FCF Yield—

Net Debt-1.97M $

Net Debt/EBITDA0.28

Balance Sheet

Debt/Equity0.01

Current Ratio1.42

Quick Ratio1.42

Book Value/Sh0.0020 USD

Cash/Share0.0050 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split38:1

Split DateJun 16, 2025

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.494.49M

Float56.28M

Insiders88.38%

Institutions0.29%

Short Interest

Short Ratio1.8d

Short % Float1.63%

Short % Out.0.18%

Shares Short903.04K

Short (prev mo.)760.77K

Technical

SMA 507.920 (-33.1%)

SMA 20020.39 (-74.0%)

Beta1.49

S&P 52W Chg21.00%

Avg Vol (30d)153.04K

Avg Vol (10d)181.49K

Technical Indicators

RSI (14)38.1

MACD-0.6580

MACD Signal-0.9034

MACD Hist.+0.2454

BB Upper6.303 USD

BB Middle5.595 USD

BB Lower4.887 USD

BB Width25.30%

ATR (14)0.6607 USD

Vol Ratio (20d)0.79x